Replies to post #157543 on Arrayit Corporation (ARYC)

[rokkdatstock]

If the tweets were true...nothing.could.stop.ARYC.from.posting.audited.financials...But for year after year the promise of financials turned out to be completely and utterly false....A P&D tactic used over and over.

[BBstocks77]

That's true

ARYC EXTRA INFO BELOW FOR ALL NEW INVESTORS

Better drugs by micro arrays by mark schena
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.477.4431&rep=rep1&type=pdf

This is a highly undervalued Silicon Valley biotech company.
http://www.arrayit.com/

CLIA Laboratory Demographic Information Report: CLIA Number: 05D2147467

https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2

http://arrayit.com/Clinical/CLIA_Laboratory/clia_laboratory.html


Global DNA Microarray Market top players : Arrayit
https://www.marketwatch.com/press-release/dna-and-gene-chip-market-overview-growth-factors-and-competitive-players-till-2027-2019-01-31?siteid=bigcharts&dist=bigcharts


Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

@Arrayit on Twitter for recent updates. Please note: every Tweet the company posts is as good as PR; the SEC has deemed the Social Media as a valid alternative advise to the public.
http://twitter.com/arrayit
https://blurbhouse.com/arrayit

Instagram:
https://www.instagram.com/p/BcCmCO4FLoF/

The ARYC charts:

http://stockcharts.com/h-sc/ui?s=Aryc
https://www.stockscores.com/charts/charts/?ticker=aryc
https://www.stockcharts.com/h-sc/ui?s=aryc
http://schrts.co/HKuDiUxM
https://www.tradingview.com/symbols/OTC-ARYC/

Arrayit Corporation patents info:
Arrayit’s patented (U.S. Patent 6,101,946) microarray printing technology is differentiated from other techniques in the market because other companies are limited by what they can deposit on a microarray; specifically DNA. The Arrayit technology can deposit any kind of molecule on a microarray, including DNA, proteins, antibodies, patient samples, diagnostic elements, and other compounds. This unique technology gives the Company a competitive advantage in the types of future diagnostic products that it develops and commercializes, as well as freedom to operate in the microarray manufacturing marketplace.
https://t.co/EMXlE743rz
https://www.google.com/search?source=hp&ei=Pv2yWqSJH6Xm_QaJ1rjAAg&q=arrayit+patents&oq=arrayit+patents&gs_l=psy-ab.3..35i39k1.955.5575.0.10174.22.17.4.0.0.0.220.1999.3j13j1.17.0..2..0...1.1.64.psy-ab..1.21.2151.0..0j0i3k1j0i131k1j0i10k1j0i22i30k1.0.RymOnqXRrqE

https://patents.justia.com/inventor/mark-schena

https://patents.justia.com/patent/20050153318

Sunnyvale, CA, July 6, 2005 – On July 5th, the United States Patent and Trademark Office (USPTO) awarded Arrayit a landmark patent in the field of genotyping and human diagnostics. United States Patent 6,913,879 entitled “Microarray method of genotyping multiple samples at multiple loci” gives the company a major patent position in the rapidly expanding medical diagnostics market. Based on pioneering research by the company’s Visiting Scholar Dr. Mark Schena, the 879’ patent teaches methods of genotyping many patients at once, rather than one patient at a time as with traditional approaches. TeleChem’s patented multi-patient methods are rapid, accurate and highly cost-effective. In one embodiment, the “Schena patent” places spots of patient DNA on a glass substrate, allowing as many as 100,000 patients to be screened in a single microarray test. The massively parallel multi-patient format reduces the cost of genotyping by 1,000-fold and ensures 100% accuracy. In another embodiment, the multi-patient microarrays are manufactured using TeleChem’s widely used contact printing technology (U.S. 6,101,946), providing the customer with seamless patented integration of both manufacturing and genotyping. By virtue of 879’ patent issuance, TeleChem is well positioned to address the expanding $22 billion global in vitro diagnostics market.




Please follow ARYC on Facebook for more updates
https://www.facebook.com/Arrayit/

Youtube video link:

Arrayit Products are widely used and are compatible with most microarray scanners. If you look at this list of array suppliers, ARYC has products for BOTH genomic microarray and protein microarray:

https://www.moleculardevices.com/systems/microarray-systems/array-suppliers

https://www.moleculardevices.com/systems/microarray-systems/array-suppliers#tab-1

Their products are also sold by secondary lab supplier companies like:

https://www.laboratory-equipment.com/mocroarray/microarray-wash-stations-trays-tubes-arrayit.php

http://www.bc-bio.com/en/product_show.php?id=54
http://www.biosurplus.com/store/models/19495-spotbot/
https://www.amazon.com/Arrayit-Arrayit-Microarray-Centrifuge/dp/B00GDFSD7S
https://www.amazon.com/Pinnertest-Intolerance-Sensitivity-Microarray-Technology/dp/B07L6P7Q36
http://www.labx.com/item/arrayit-innoscan-910-910al-and-1100al-high-performance/595371

http://www.bc-bio.com/en/product_show.php?id=51
https://www.terrauniversal.com/?action=search&s=arrayit


Arrayit Corporation
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone [phone]
FAX [phone]
Email [e-mail]
Web www.arrayit.com

http://www.arrayit.com/

If you live in or near the bay area you can stop by to visit the company. They are very shareholder friendly.

[MGStocks]

If only 50% return on billing (which I think is conservative) it’s dollar land